These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25037221)

  • 21. High expression of semicarbazide-sensitive amine oxidase genes AOC2 and AOC3, but not the diamine oxidase gene AOC1 in human adipocytes.
    Heniquez A; Meissonnier G; Visentin V; Prévot D; Carpéné C
    Inflamm Res; 2003 Apr; 52 Suppl 1():S74-5. PubMed ID: 12755418
    [No Abstract]   [Full Text] [Related]  

  • 22. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
    Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U
    Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The receptor tyrosine kinase regulator Sprouty1 is a target of the tumor suppressor WT1 and important for kidney development.
    Gross I; Morrison DJ; Hyink DP; Georgas K; English MA; Mericskay M; Hosono S; Sassoon D; Wilson PD; Little M; Licht JD
    J Biol Chem; 2003 Oct; 278(42):41420-30. PubMed ID: 12882970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y; San-Marina S; Yang L; Khoury H; Minden MD
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mutant Ahr allele protects the embryonic kidney from hydrocarbon-induced deficits in fetal programming.
    Nanez A; Ramos IN; Ramos KS
    Environ Health Perspect; 2011 Dec; 119(12):1745-53. PubMed ID: 21803694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development.
    Hartwig S; Ho J; Pandey P; Macisaac K; Taglienti M; Xiang M; Alterovitz G; Ramoni M; Fraenkel E; Kreidberg JA
    Development; 2010 Apr; 137(7):1189-203. PubMed ID: 20215353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of WT1 in Embryonic Development and Normal Organ Homeostasis.
    Wilm B; Muñoz-Chapuli R
    Methods Mol Biol; 2016; 1467():23-39. PubMed ID: 27417957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of taurine transporter gene (TauT) by WT1.
    Han X; Chesney RW
    FEBS Lett; 2003 Apr; 540(1-3):71-6. PubMed ID: 12681485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repression of Pax-2 by WT1 during normal kidney development.
    Ryan G; Steele-Perkins V; Morris JF; Rauscher FJ; Dressler GR
    Development; 1995 Mar; 121(3):867-75. PubMed ID: 7720589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
    Werner H; Roberts CT; Rauscher FJ; LeRoith D
    J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WT1-mediated gene regulation in early urogenital ridge development.
    Klattig J; Sierig R; Kruspe D; Makki MS; Englert C
    Sex Dev; 2007; 1(4):238-54. PubMed ID: 18391535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expansion of the renal capsular stroma, ureteric bud branching defects and cryptorchidism in mice with Wilms tumor 1 gene deletion in the stromal compartment of the developing kidney.
    Weiss AC; Rivera-Reyes R; Englert C; Kispert A
    J Pathol; 2020 Nov; 252(3):290-303. PubMed ID: 32715478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the Wilms' tumor gene WT1 in the murine urogenital system.
    Pelletier J; Schalling M; Buckler AJ; Rogers A; Haber DA; Housman D
    Genes Dev; 1991 Aug; 5(8):1345-56. PubMed ID: 1651275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Wilms' tumor gene Wt1 is required for normal development of the retina.
    Wagner KD; Wagner N; Vidal VP; Schley G; Wilhelm D; Schedl A; Englert C; Scholz H
    EMBO J; 2002 Mar; 21(6):1398-405. PubMed ID: 11889045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of amine oxidase copper containing 1 inhibits tumor progression by suppressing IL-6/JAK/STAT3 pathway activation in hepatocellular carcinoma.
    Ding Q; Lin D; Zhou Y; Li F; Lai J; Duan J; Chen J; Jiang C
    Oncol Lett; 2021 Dec; 22(6):857. PubMed ID: 34777591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene.
    Dame C; Kirschner KM; Bartz KV; Wallach T; Hussels CS; Scholz H
    Blood; 2006 Jun; 107(11):4282-90. PubMed ID: 16467207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
    J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Despite WT1 binding sites in the promoter region of human and mouse nucleoporin glycoprotein 210, WT1 does not influence expression of GP210.
    Olsson M; English MA; Mason J; Licht JD; Ekblom P
    J Negat Results Biomed; 2004 Dec; 3():7. PubMed ID: 15613247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wilms' tumour protein Wt1 stimulates transcription of the gene encoding vascular endothelial cadherin.
    Kirschner KM; Sciesielski LK; Scholz H
    Pflugers Arch; 2010 Nov; 460(6):1051-61. PubMed ID: 20811903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WT1 and kidney progenitor cells.
    Kreidberg JA
    Organogenesis; 2010; 6(2):61-70. PubMed ID: 20885852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.